General Information of the Compound
| Compound ID |
CP0376633
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(rac)-3-(3-(1-(3-(4-(Pyrimidin-2-yl)piperazin-1-yl)propyl)-1H-1,2,3-triazol-4-yl)propyl)-1-m-tolyl-2,3,4,5-tetrahydro-1Hbenzo[d]azepine-7,8-diol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H42N8O2
|
||||||||||||||||||
| Molecular Weight |
582.753
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(c1)C1CN(CCCc2cn(CCCN3CCN(CC3)c3ncccn3)nn2)CCc2cc(O)c(O)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H42N8O2/c1-25-6-2-7-26(20-25)30-24-39(15-9-27-21-31(42)32(43)22-29(27)30)12-3-8-28-23-41(37-36-28)14-5-13-38-16-18-40(19-17-38)33-34-10-4-11-35-33/h2,4,6-7,10-11,20-23,30,42-43H,3,5,8-9,12-19,24H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
LFKIBYQDTRIPSY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01195, D(1A) dopamine receptor